EHA: Ibrutinib + Venetoclax de primera línea para la leucemia linfocítica crónica

By In The News
June 12, 2021 in The Headlines

Recommended Posts

In The News

Posted June 12, 2021

- Share

Posted June 12, 2021

European Hematology Association - Ibrutinib + Venetoclax de primera línea es superior al clorambucil + obinutuzumab para la leucemia linfocítica crónica/linfoma de linfocitos pequeños LA HAYA, Países Bajos, 12 de junio de 2021 /PRNewswire/ -- La combinación de ibrutinib y venetoclax puede...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221833
2. Jaydee
  17668
3. deicer
  13227
4. Kip Powick
  12297
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.2k
- Total Posts
  
  564.4k

Sign In

EHA: Ibrutinib + Venetoclax de primera línea para la leucemia linfocítica crónica

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support